ASHM16 Speaker Highlight.jpg

October 2016:  WORKING in the HIV HEALTH SECTOR? Join the Australasian HIV & AIDS Conference—a top-rated educational program (Wednesday 16 - Friday 18 November 2016) in Adelaide, Australia with world-renowned speakers – learn about new research findings in the sector + increase your knowledge to develop new work practices. This 3-day conference in November is a key opportunity to network + form important collaborations with hundreds of the key people working in HIV in Australasia – keeping you informed of who’s who and of potential opportunities.

This year's annual conference happens back-to-back with the Australasian Sexual Health Conference (Monday 14 - Wednesday 16 November 2016) creating a full week of high quality research in our fields. 


Program Overview Available

Keep updated by visiting the conference website as we update with more information on the program and invited speakers. Scroll down below and read through some of the selected speakers and program highlights that shouldn't be missed:


REGISTER ONLINE HERE before 28 October

Alternatively download the registration flyer PDF here


Have a Twitter account?

You can also follow the of-the-moment live feeds from the conference and join in on the dialogue via @ASHMMedia with the conference hashtag #ASHM16


2016 Conference Highlights

      • Fostering a comprehensive response to HIV in low prevalence settings and populations including heterosexually-acquired HIV, migrant populations and in regional and remote settings
      • Reviewing the early implementation of PrEP and identifying priority issues for clinicians, researchers and affected communities 
      • Ensuring professional and skills development are a priority in the development of sessions and other learning opportunities held within the conference  
      • Enabling greater access and discussion around poster presentations through scheduling of dedicated concurrent sessions


Go back to the top of the page


Program Highlights: Theme A

Understanding and identifying HIV and related infections: Basic Science, Biology and Pathogenesis 

This theme explores fundamentals of HIV and laboratory based research and practice. Areas of focus include the translation of basic research to clinical and laboratory based practice in Australia and the Region.

Go back to the top of the page


Program Highlights: Theme B


Managing HIV and related infections: Clinical management and the lived experience of HIV

This theme highlights the clinical management of HIV, through presenting latest research findings relating to the diagnosis and treatment of HIV and the experience of living with HIV in Australia and the Region.

Go back to the top of the page



Program Highlights: Theme C


Preventing HIV and related infections: Epidemiology and Prevention in Australia and the Region

This theme explores the range of prevention initiatives from behavioural and social research to biomedical and includes epidemiological and surveillance research aimed at understanding HIV for prevention purposes in Australia and the Region.

Go back to the top of the page


Program Highlights: Theme D


Policy, Politics and Cultural issues of HIV and related infections in Australia and internationally

This theme examines issues and experiences specific to populations affected by HIV. Papers submitted for this theme will have a population dimension and will include country specific sessions which might cover a range of research areas, including social research, health and community advocacy.

Go back to the top of the page


Keynote Speaker Highlights

      • Doctor Jared Baeten, MD, PhD — As Vice Chair and Professor in the Department of Global Health at the University of Washington, his research focuses on the prevention of HIV-1 and other sexually transmitted diseases, including clinical trials of novel prevention interventions, epidemiologic studies of risk factors for HIV-1 transmission, and biobehavioral and implementation science research aimed at optimizing prevention delivery. He led the Partners PrEP Study and MTN-020/ASPIRE, randomized clinical trials the proved the efficacy of tenofovir-based pills and the dapivirine vaginal ring as pre-exposure prophylaxis (PrEP) against HIV-1 acquisition.

      • Lisa Bastien — As the Program Manager of the Western Australian Department of Health’s Sexual Health and Blood-borne Virus Program since 2005 and was recently appointed as Manager of the WA HIV Case Management Program.  Lisa is responsible for planning and monitoring the HIV policy and public health response in Western Australia.

      • Doctor Valerie Delpech — As a public health consultant based at Public Health England, A/Prof Delpech leads the national surveillance and monitoring of HIV infections and people in HIV care. Her research interests have focused on better understanding the dynamics of HIV and other STI epidemics and their impact on vulnerable communities. 

      • Doctor Joseph Doyle — He is a specialist in infectious diseases and public health medicine, and works at the intersection between clinical medicine, implementation research and health policy. He has particular research interests in epidemiology, prevention and management of blood-borne viruses. He is currently the co-principal investigator of the HIV/HCV co-infection Eliminate Hepatitis C (co-EC) Study and chief investigator of the NHMRC Eliminate Hepatitis C (EC) Partnership.

      • Amber D'Souza — As A/Prof of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, Dr. D’Souza leads a research program on infectious causes of cancer, focusing on understudied areas such as anal cancer among MSM, and oral HPV causing tonsillar cancers. She is the co-PI of the datacenter for the Multicenter AIDS Cohort Study (MACS).

      • Doctor Angela Kelly-Hanku — Angela has a background in social science and public health, and has been a long-term collaborator with the Kirby Institute. Angela leads a large multidisciplinary unit at the Papua New Guinea Institute of Medical Research (IMR), working on projects in sexual health, reproductive health, HIV, violence, gender and sexuality and TB. As well as her role at the Kirby Institute, Angela will continue in her role with the IMR as the Head of the Sexual and Reproductive Health Unit, based full-time in Goroka, PNG.

      • Doctor Cindy Liu, MD, MPH, PhD — As Assistant Research Prof. in the Department of Environmental and Occupational Health at the George Washington Milken Institute School of Public Health, the translational goals of her work are to advance our understanding of the role of the microbiome in modifying host susceptibility to pathogens such as HIV, with the goal of leveraging this knowledge to develop novel microbiome-based preventive strategies. Her other research focuses on reducing antibiotic-resistant infections through improving antimicrobial stewardship and the development of rapid diagnostics. 

      • Professor John Murray — As a Professor of Applied Mathematics at UNSW, he is working mainly in applications of mathematics to biology. Largely that focus has been on mathematical modelling of the in vivo dynamics of viral infections, particularly HIV and hepatitis B virus. One of those projects has been to assess the likely impact of HIV gene therapy, originally with Johnson & Johnson Research and now with Calimmune.

      • Doctor Kedar Narayan — He is a group leader at the recently opened Center for Molecular Microscopy (CMM) at the Frederick National Laboratory for Cancer Research. At his post-doc at the laboratory of Sriram Subramaniam at NIH, Kedar developed Focused Ion Beam Scanning Electron Microscopy (FIB-SEM) as a high-resolution electron microscopic tool to study HIV-cell interactions, as well as an enabler for chemical imaging. At the CMM, Kedar continues to work with industry partners to develop FIB-SEM applications in biology.

Go back to the top of the page


REGISTER ONLINE HERE before 28 October

Alternatively download the registration flyer PDF here


ASHM16 Reasons to Attend - Survey 2015.jpg

Go back to the top of the page 


​About the Australasian HIV & AIDS Conference

The 2016 Australasian HIV&AIDS Conference marks the 26th Annual Conference of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM)—and continues its run as the premier HIV Conference in Australia and the Asia and Pacific region.

The conference was first launched in 1989 in response to the emerging area of clinical care for HIV. Since its inception as a small meeting of medical practitioners brought together under the umbrella of ASAP (the Australian Society of AIDS Physicians) the HIV&AIDS Conference has grown into the region’s premier medical/scientific conference in the HIV and related diseases sector, attracting speakers and delegates from around the world.

Since 2005 the Conference has been held back-to-back with the Australasian Sexual Health Conference with one full day of overlap, providing a unique opportunity to look at HIV in the broader context of sexual health. Together, the conferences attract more than 1000 delegates from across the region.

Delegates to the conference come from a range of professional backgrounds including basic science, clinical medicine, community programs, education, epidemiology, indigenous health, international and regional issues, nursing and allied health, policy, primary care, public health and prevention, and social research.

See the Abstracts, Presentations, Photos and more from the 2015 Conference by visiting the 2015 Conference Website here